Evolution of suboptimal renal transplantations: experience of a single Spanish center

Transplant Proc. 2006 Oct;38(8):2394-5. doi: 10.1016/j.transproceed.2006.08.078.

Abstract

The increase in patients on dialysis awaiting transplantation has led to the use of grafts from suboptimal donors. The aim of this study was to analyze the function of suboptimal grafts. The secondary objectives were to study vascular and urological complications, as well as delayed renal function and acute rejection episodes. The study included 135 transplantations performed over 4 years with 27% of grafts being from suboptimal donors. Early graft loss was 12%, of which 69% were due to vascular thrombosis. These thromboses were more frequent among grafts from suboptimal donors (30% vs 4%, P < .001). There were no significant differences between the groups in the incidence of acute rejection episodes (17% vs 13%) or delayed graft function (14% vs 13%). A greater incidence of urologic complications was observed among recipients of grafts from older donors. The 1-year creatinine clearance was significantly lower among recipients of grafts from older donors (73 +/- 19 vs 51 +/- 14 mL/min, P < .0001). Sequential immunosuppressive therapy resulted in a lack of significant differences in creatinine clearance at 6 months, 1 year, or 2 years after transplantation between suboptimal grafts with cold ischemia greater or less than 20 hours or in warm ischemia greater or less than 60 minutes. Logistic regression analysis showed that the best determinant of graft loss was donor age older than 60 years. Accordingly, grafts from suboptimal donors were more likely to be lost during the first month after transplantation, particularly because of thrombosis, which was not due to a higher degree of technical complexity of the transplant operation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cadaver
  • Creatinine / metabolism
  • Follow-Up Studies
  • Graft Rejection / epidemiology
  • Humans
  • Incidence
  • Kidney Function Tests
  • Kidney Transplantation / physiology*
  • Retrospective Studies
  • Spain
  • Thrombosis / mortality
  • Tissue Donors / statistics & numerical data*
  • Treatment Outcome

Substances

  • Creatinine